These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 21172965)

  • 1. Diffusion-weighted magnetic resonance imaging for monitoring prostate cancer progression in patients managed by active surveillance.
    Morgan VA; Riches SF; Thomas K; Vanas N; Parker C; Giles S; Desouza NM
    Br J Radiol; 2011 Jan; 84(997):31-7. PubMed ID: 21172965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nine-year Follow-up for a Study of Diffusion-weighted Magnetic Resonance Imaging in a Prospective Prostate Cancer Active Surveillance Cohort.
    Henderson DR; de Souza NM; Thomas K; Riches SF; Morgan VA; Sohaib SA; Dearnaley DP; Parker CC; van As NJ
    Eur Urol; 2016 Jun; 69(6):1028-33. PubMed ID: 26482887
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serial changes in tumour measurements and apparent diffusion coefficients in prostate cancer patients on active surveillance with and without histopathological progression.
    Sushentsev N; Caglic I; Rundo L; Kozlov V; Sala E; Gnanapragasam VJ; Barrett T
    Br J Radiol; 2022 Mar; 95(1131):20210842. PubMed ID: 34538077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffusion-weighted magnetic resonance imaging: a potential non-invasive marker of tumour aggressiveness in localized prostate cancer.
    deSouza NM; Riches SF; Vanas NJ; Morgan VA; Ashley SA; Fisher C; Payne GS; Parker C
    Clin Radiol; 2008 Jul; 63(7):774-82. PubMed ID: 18555035
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of diffusion-weighted magnetic resonance imaging in men with untreated localised prostate cancer on active surveillance.
    van As NJ; de Souza NM; Riches SF; Morgan VA; Sohaib SA; Dearnaley DP; Parker CC
    Eur Urol; 2009 Dec; 56(6):981-7. PubMed ID: 19095345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multiparametric MRI in detection and staging of prostate cancer.
    Boesen L
    Dan Med J; 2017 Feb; 64(2):. PubMed ID: 28157066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of Diffusion Kurtosis Imaging Versus Standard Diffusion Imaging for Detection and Grading of Peripheral Zone Prostate Cancer.
    Roethke MC; Kuder TA; Kuru TH; Fenchel M; Hadaschik BA; Laun FB; Schlemmer HP; Stieltjes B
    Invest Radiol; 2015 Aug; 50(8):483-9. PubMed ID: 25867657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-weighted magnetic resonance imaging in prostate cancer patients on active surveillance one year after diagnosis and before repeat biopsy.
    Vasarainen H; Lahdensuo K; Savolainen R; Ruutu M; Taari K; Rannikko A
    Scand J Urol; 2013 Dec; 47(6):456-61. PubMed ID: 23327661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apparent diffusion coefficient as a predictive biomarker of prostate cancer progression: value of fast and slow diffusion components.
    Giles SL; Morgan VA; Riches SF; Thomas K; Parker C; deSouza NM
    AJR Am J Roentgenol; 2011 Mar; 196(3):586-91. PubMed ID: 21343500
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy.
    Woodfield CA; Tung GA; Grand DJ; Pezzullo JA; Machan JT; Renzulli JF
    AJR Am J Roentgenol; 2010 Apr; 194(4):W316-22. PubMed ID: 20308476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between apparent diffusion coefficients at 3.0-T MR imaging and Gleason grade in peripheral zone prostate cancer.
    Hambrock T; Somford DM; Huisman HJ; van Oort IM; Witjes JA; Hulsbergen-van de Kaa CA; Scheenen T; Barentsz JO
    Radiology; 2011 May; 259(2):453-61. PubMed ID: 21502392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging.
    Rosenkrantz AB; Kopec M; Kong X; Melamed J; Dakwar G; Babb JS; Taouli B
    J Magn Reson Imaging; 2010 Jun; 31(6):1387-94. PubMed ID: 20512891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined use of diffusion-weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection.
    Reinsberg SA; Payne GS; Riches SF; Ashley S; Brewster JM; Morgan VA; deSouza NM
    AJR Am J Roentgenol; 2007 Jan; 188(1):91-8. PubMed ID: 17179350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diffusion-weighted MRI for locally recurrent prostate cancer after external beam radiotherapy.
    Morgan VA; Riches SF; Giles S; Dearnaley D; deSouza NM
    AJR Am J Roentgenol; 2012 Mar; 198(3):596-602. PubMed ID: 22357998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diffusion-weighted magnetic resonance imaging for prediction of insignificant prostate cancer in potential candidates for active surveillance.
    Kim TH; Jeong JY; Lee SW; Kim CK; Park BK; Sung HH; Jeon HG; Jeong BC; Seo SI; Lee HM; Choi HY; Jeon SS
    Eur Radiol; 2015 Jun; 25(6):1786-92. PubMed ID: 25636416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal evaluation of apparent diffusion coefficient values as a predictor of Prostate Cancer Research International Active Surveillance reclassification.
    Ota E; Mori N; Yamashita S; Mugikura S; Ito A; Takase K
    Abdom Radiol (NY); 2022 Feb; 47(2):814-826. PubMed ID: 34882269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial experience with identifying high-grade prostate cancer using diffusion-weighted MR imaging (DWI) in patients with a Gleason score ≤ 3 + 3 = 6 upon schematic TRUS-guided biopsy: a radical prostatectomy correlated series.
    Somford DM; Hambrock T; Hulsbergen-van de Kaa CA; Fütterer JJ; van Oort IM; van Basten JP; Karthaus HF; Witjes JA; Barentsz JO
    Invest Radiol; 2012 Mar; 47(3):153-8. PubMed ID: 22293513
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo measurement of the apparent diffusion coefficient in normal and malignant prostatic tissue using thin-slice echo-planar imaging.
    Manenti G; Squillaci E; Di Roma M; Carlani M; Mancino S; Simonetti G
    Radiol Med; 2006 Dec; 111(8):1124-33. PubMed ID: 17171522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiation of prostate cancer lesions with high and with low Gleason score by diffusion-weighted MRI.
    Barbieri S; Brönnimann M; Boxler S; Vermathen P; Thoeny HC
    Eur Radiol; 2017 Apr; 27(4):1547-1555. PubMed ID: 27300199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Detection of prostate cancer with magnetic resonance imaging: optimization of T1-weighted, T2-weighted, dynamic-enhanced T1-weighted, diffusion-weighted imaging apparent diffusion coefficient mapping sequences and MR spectroscopy, correlated with biopsy and histopathological findings.
    Aydin H; Kizilgöz V; Tatar IG; Damar C; Ugan AR; Paker I; Hekimoğlu B
    J Comput Assist Tomogr; 2012; 36(1):30-45. PubMed ID: 22261768
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.